Search results for: 'engineering research and development'

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

10 Jul 2015  |  Asia Pacific  |  Market Research

APAC Contract Research Organisation (CRO) Market

An Analysis of Trends Transforming the CRO Industry

Infographics

×

The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-cli...

10 Mar 2015  |  Latin America  |  Market Research

Latin American Contract Research Organization Market

Lower Cost of Conducting Clinical Trials will Drive Growth

Infographics

×

This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support se...